secwatch.observer — SEC 8-K summary
======================================

Issuer:     Integer Holdings Corp (ITGR)
CIK:        0001114483
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001171843-22-006796
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integer Q3 sales up 12% to $343M; GAAP net income down 27% to $16M
------------------------------------------------------------------

- Sales increased 12% to $343M; GAAP EPS $0.48 vs $0.66 prior year; adjusted EPS $0.95 vs $1.05.
- Cardio & Vascular sales +14%; Cardiac Rhythm Management +8%; Advanced Surgical +17%; Electrochem +24%.
- 2022 outlook: GAAP sales $1.35-1.38B, adj. EBITDA $244-260M, adj. EPS $3.57-3.97; organic growth 4-6%.
- Total debt rose $111M to $939M due to Aran Biomedical acquisition for $129M; leverage ratio 3.8x.
- CEO expects 2023 revenue growth of 7-9% with margin expansion; supply chain delays to be recovered in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1114483/000117184322006796/0001171843-22-006796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1114483/000117184322006796/f8k_102622.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-006796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer